Bellevue Group AG

Q4 2021 13F Detailed Holdings

Location
Kuesnacht, Switzerland
Holdings as of
12/31/2021
Value ($000)
$9,701,498
Num holdings
235
Date filed
2/10/2022
Form type
13F-HR
Prev filing
11/12/2021
Next filing
5/13/2022
Note
Holdings broken out by “other managers” reported in original SEC filing, see here for holdings aggregated across other managers
Sym Issuer Name Cl CUSIP Value ($000) % Shares Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 BB Biotech AG 28-06964
2 Bellevue Asset Management AG 28-16892
3 Bellevue Asset Management (UK) Ltd. 28-20408